Exfoliative dermatitis is a severe inflammatory skin condition in which most or all of the body’s skin becomes red, inflamed, and begins to peel off in sheets or flakes. Also called erythroderma, it typically involves 75% or more of the body’s surface area and can cause systemic problems like dehydration, infection, and difficulty regulating body temperature. It is not a disease on its own but rather an extreme reaction triggered by an underlying condition, a medication, or sometimes a skin cancer.
What Causes It
The single most common trigger is a preexisting skin disease that flares out of control. Psoriasis accounts for roughly half of all cases in some analyses, making it the leading cause by a wide margin. Eczema (atopic dermatitis and other eczematous conditions) is the second most frequent culprit and has been identified as the primary cause in at least one large study. Less common skin conditions that can escalate into erythroderma include pityriasis rubra pilaris, cutaneous lupus, scabies, and certain blistering diseases.
Medications are another well-established trigger. The drug classes most frequently linked to exfoliative dermatitis are sulfonamide antibiotics, NSAIDs (especially the oxicam type), penicillin-based antibiotics, and anticonvulsants like phenytoin, carbamazepine, and lamotrigine. Allopurinol (used for gout) and the HIV drug nevirapine also carry a higher risk. Drug-induced cases can develop days to weeks after starting a new medication, which sometimes makes the connection hard to spot.
In a smaller but important subset of patients, erythroderma is the first visible sign of a blood cancer affecting the skin, particularly a type of lymphoma called Sézary syndrome or mycosis fungoides. And in up to a quarter of cases, no underlying cause is ever identified, a frustrating situation doctors call “idiopathic” erythroderma.
What Happens in the Skin
Normally, skin cells are produced at the base of the outer skin layer, slowly migrate to the surface over about a month, and quietly shed. In exfoliative dermatitis, a cascade of inflammatory signals causes the skin’s cell production to accelerate dramatically. The result is a massive, body-wide turnover of skin cells. New cells push to the surface far faster than usual, and the outermost layer cannot hold together properly, leading to widespread peeling and flaking.
This isn’t just a cosmetic problem. The skin is the body’s largest organ and serves as a barrier against infection, a regulator of temperature, and a container for fluids and proteins. When that barrier breaks down across the entire body, serious complications follow.
Symptoms and What It Feels Like
The hallmark is intense, widespread redness that can range from bright red to a deeper dusky tone depending on skin color. Scaling follows, sometimes as fine, powdery flakes and other times as large, plate-like sheets of skin. The affected skin often feels tight, hot, and extremely itchy or painful. Many people describe a burning sensation.
Because the condition is systemic, it comes with symptoms that go well beyond the skin. Fever, chills, fatigue, joint pain, and swollen lymph nodes are common. The skin loses its ability to regulate temperature effectively, so patients often feel cold even in warm environments and may develop hypothermia. Fluid evaporates through the damaged skin at an accelerated rate, leading to dehydration and drops in key blood proteins. Heart rate increases as the cardiovascular system works harder to compensate, and electrolyte imbalances can develop. Tachycardia (a noticeably fast heartbeat) is a frequent finding.
How It Is Diagnosed
Recognizing erythroderma itself is usually straightforward: widespread redness and peeling covering most of the body is hard to miss. The real diagnostic challenge is figuring out what caused it. A thorough history of skin diseases, recent medications, and any new exposures is the starting point.
Skin biopsies are commonly taken, but they have limitations. When erythroderma is caused by scabies or certain blistering diseases, the biopsy findings are distinctive and confirm the diagnosis quickly. For the more common causes, like psoriasis, eczema, drug reactions, and pityriasis rubra pilaris, the microscopic findings overlap significantly. All of them show thickened skin, abnormal surface cells, and clusters of immune cells, making it difficult to tell them apart under the microscope. Multiple biopsies, taken from different body sites and sometimes repeated over time, may be needed. Blood work helps assess the severity of complications and can flag blood cancers like Sézary syndrome.
Complications and Risks
Exfoliative dermatitis is a potentially life-threatening condition. The combination of fluid loss, protein depletion, temperature instability, and a compromised skin barrier creates a perfect setup for dangerous infections. In a large study following 309 patients over 12 years, 9.1% of patients died during the follow-up period. Sepsis (overwhelming bloodstream infection) was the cause of death in nearly 90% of those cases, with cardiovascular events accounting for the rest.
The risk is not evenly distributed. Patients whose erythroderma was caused by skin lymphomas (Sézary syndrome and mycosis fungoides) had dramatically higher mortality rates, with roughly 30 to 34% dying during follow-up. Older adults and those with other health conditions are also at greater risk. Bacterial skin infections, particularly from staph bacteria, are a constant concern, and repeated skin swabs may be needed to catch infections early.
Treatment and What to Expect
The first priority is stabilizing the body. People with significant dehydration, electrolyte disturbances, fever, or rapid heart rate typically need hospital admission. Supportive care focuses on replacing lost fluids, correcting protein and electrolyte levels, and maintaining body temperature. Gentle moisturizers and wet wraps help soothe the skin and reduce water loss through the damaged barrier. Antibiotics may be started if there are signs of bacterial infection or a high risk of one developing.
The second, equally important step is identifying and addressing the underlying cause. If a medication triggered the reaction, stopping that drug is essential and often leads to gradual improvement over days to weeks. If an existing skin condition like psoriasis flared into erythroderma, treatment targets that condition aggressively. For psoriasis-driven erythroderma specifically, immune-suppressing medications are the backbone of treatment. Cyclosporine works relatively quickly and is often used to get the acute flare under control, while methotrexate tends to work more slowly but is effective for maintaining remission. These two drugs, sometimes combined with topical treatments, show clinical improvement in over 60% of cases. Newer biologic therapies targeting specific immune pathways are an option when these first-line treatments fail or can’t be used.
Recovery timelines vary widely. Drug-induced cases may resolve within a few weeks once the offending medication is stopped. Erythroderma caused by chronic skin diseases like psoriasis often takes longer to bring under control and may recur. Idiopathic cases are the most unpredictable, sometimes persisting for months and requiring ongoing treatment to keep symptoms manageable.
Who Gets It
Exfoliative dermatitis is uncommon. It affects men more often than women, with most studies reporting a male-to-female ratio of roughly 2:1 to 3:1. The average age at onset tends to fall between 40 and 60, though it can occur at any age, including in children. People with long-standing, poorly controlled skin diseases are at the highest risk, particularly those with extensive psoriasis or severe eczema. Having a history of drug reactions also increases susceptibility.